Shenzhen - Delayed Quote CNY

JOLLY PHARMACEUTICAL (300181.SZ)

17.52
+0.27
+(1.57%)
As of 11:16:34 AM GMT+8. Market Open.
Loading Chart for 300181.SZ
  • Previous Close 17.25
  • Open 17.19
  • Bid 17.56 x --
  • Ask 17.58 x --
  • Day's Range 17.11 - 17.58
  • 52 Week Range 11.53 - 18.50
  • Volume 11,560,050
  • Avg. Volume 20,261,739
  • Market Cap (intraday) 12.288B
  • Beta (5Y Monthly) 0.20
  • PE Ratio (TTM) 22.46
  • EPS (TTM) 0.78
  • Earnings Date --
  • Forward Dividend & Yield 0.60 (3.48%)
  • Ex-Dividend Date May 26, 2025
  • 1y Target Est 22.00

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, it offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, the company provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. The company also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. Zhejiang Jolly Pharmaceutical Co.,LTD was founded in 1995 and is based in Huzhou, the People's Republic of China.

www.zuoli.com

2,125

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300181.SZ

View More

Performance Overview: 300181.SZ

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is 000001.SS (000001.SS) .

YTD Return

300181.SZ
18.35%
000001.SS (000001.SS)
1.59%

1-Year Return

300181.SZ
16.15%
000001.SS (000001.SS)
11.59%

3-Year Return

300181.SZ
128.17%
000001.SS (000001.SS)
3.66%

5-Year Return

300181.SZ
239.22%
000001.SS (000001.SS)
15.67%

Compare To: 300181.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300181.SZ

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    12.10B

  • Enterprise Value

    11.89B

  • Trailing P/E

    21.97

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.40

  • Price/Book (mrq)

    3.88

  • Enterprise Value/Revenue

    4.36

  • Enterprise Value/EBITDA

    18.18

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.02%

  • Return on Assets (ttm)

    9.34%

  • Return on Equity (ttm)

    18.23%

  • Revenue (ttm)

    2.73B

  • Net Income Avi to Common (ttm)

    546.51M

  • Diluted EPS (ttm)

    0.78

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    741.03M

  • Total Debt/Equity (mrq)

    16.76%

  • Levered Free Cash Flow (ttm)

    -275.08M

Research Analysis: 300181.SZ

View More

Company Insights: 300181.SZ

Research Reports: 300181.SZ

View More

People Also Watch